Ngs Sample Preparation Market Projected to Be Resilient by 2032
Sales of NGS sample preparation products were valued at US$ 3.8 Billion in FY 2021, and is likely to exhibit a Y-o-Y increase of 10.5% in 2022, reaching US$ 4.2 Billion.
During the forecast period ranging from 2022 to 2032, market demand is expected to surge at a CAGR of 7.3%, expected to reach US$ 8.5 Billion.
The global NGS sample preparation market is expected to grow significantly over the forecast period, driven by the increasing demand for personalized medicine and the increasing use of NGS for cancer diagnostics. Additionally, the increasing need for cost–effective sequencing methods and the development of high–throughput NGS technologies are expected to boost the demand for NGS sample preparation solutions. The increasing prevalence of infectious diseases, such as HIV, is also expected to fuel the market demand. Furthermore, the increasing collaborations between government and private institutions to promote NGS research and the rising awareness about NGS technology are expected to drive the market.
Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5932?pk
Competitive Landscape
Offering new sample items with cutting-edge technology, collaborating with current manufacturers, making acquisitions, and obtaining regulatory clearances are just a few of the important expansion methods used by major industry competitors. The following are some noteworthy developments:
QIAGEN N.V. introduced the QIAseq DIRECT SARS-CoV-2 Kit in April 2021, a viral genome enrichment and library preparation solution that would drastically minimize library turnaround times and the usage of plastics in NGS.
In addition, Thermo Fisher Scientific approved a formal deal to buy PPD Inc. for US$ 17.4 billion, with the goal of boosting innovation, increasing drug development productivity, and fostering advanced clinical research.
Swift Biosciences was bought by Integrated DNA Technologies (IDT) Inc. in May 2021 to expand its NGS library preparation genomics kits for academic, translational, and clinical research. Swift develops and commercializes NGS Library Prep Kits that maximize data output, provide comprehensive coverage, and reduce sequencing costs, while IDT is a leader in developing and production nucleic acid products for academic and commercial research, agriculture, medical diagnostics, pharmaceutical development, and synthetic biology.
Key Segments Covered in the NGS Sample Preparation Industry Report
By Product Type :
NGS Sample Preparation Instruments
NGS Sample Preparation Kits, Reagents & Consumables
By Application :
Drug & Biomarker Discovery
Diagnostics
Precision Medicines
Others
Agriculture
Animal Research
By End User :
Hospitals & Diagnostic Centers
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
Others
CROs
CMOs
By Region :
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Why are Manufacturers of NGS Sample Preparation Products Looking to India for Future Growth?
Over the years, the Indian Healthcare Industry has grown significantly
The Indian healthcare business has seen substantial growth over the years, with value-based care, smart healthcare, and blockchain technology all making major progress. Furthermore, given the increasing complexity of chronic and infectious illnesses, NGS-based diagnostics has become increasingly important.
NGS screening has been widely used in fields including non-invasive prenatal testing, cancer diagnosis, and bacterial and viral infection diagnosis. Prenatal screening is a promising topic since it can assist conceiving couples in determining the existence of genetic abnormalities in the fetus, such as Down’s syndrome. A CAGR of 6.6% is anticipated for the market until 2032.
Get More insights on this: https://www.factmr.com/report/ngs-sample-preparation-market
Appreciate the creator